학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 133건 | 목록 1~10
Academic Journal
Sugawara T; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Nevedomskaya E; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Heller S; Nuvisan ICB GmbH, Berlin, Germany.; Böhme A; Nuvisan ICB GmbH, Berlin, Germany.; Lesche R; Nuvisan ICB GmbH, Berlin, Germany.; von Ahsen O; Nuvisan ICB GmbH, Berlin, Germany.; Grünewald S; Nuvisan ICB GmbH, Berlin, Germany.; Nguyen HM; Department of Urology, University of Washington, Seattle, WA, USA.; Corey E; Department of Urology, University of Washington, Seattle, WA, USA.; Baumgart SJ; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Georgi V; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Pütter V; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Fernández-Montalván A; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Vasta JD; Promega Corporation, Madison, WI, USA.; Robers MB; Promega Corporation, Madison, WI, USA.; Politz O; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Mumberg D; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Haendler B; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.
Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Academic Journal
Sartori G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Gaudio E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Cascione L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Mascia M; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Barreca M; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Palermo, Italy.; Arribas AJ; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Licenziato L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Department of Veterinary Sciences, University of Turin, Turin, Italy.; Golino G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Ferragamo A; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Pileri S; Division of Diagnostic Haematopathology, European Institute of Oncology, Milan, Italy.; Damia G; Laboratory of Molecular Pharmacology, Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.; Zucca E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; Stathis A; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, USI, Lugano, Switzerland.; Politz O; Bayer AG, Pharmaceuticals, Research & Development, Berlin, Germany.; Wengner AM; Bayer AG, Pharmaceuticals, Research & Development, Berlin, Germany.; Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Academic Journal
Heller S; Nuvisan ICB GmbH, Berlin, Germany.; Glaeske S; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Gluske K; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Paul J; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Böhme A; Nuvisan ICB GmbH, Berlin, Germany.; Janzer A; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Roider HG; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Montebaur A; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Nicke B; Nuvisan ICB GmbH, Berlin, Germany.; Lesche R; Nuvisan ICB GmbH, Berlin, Germany.; von Ahsen O; Nuvisan ICB GmbH, Berlin, Germany.; Politz O; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Liu N; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany.; Fosun Pharma, No. 1289 Yishan Road, Shanghai City, China.; Gorjánácz M; Bayer AG, Pharmaceuticals, Research & Early Development Oncology, Berlin, Germany. matyas.gorjanacz@bayer.com.
Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE
Academic Journal
Zitzmann-Kolbe S; Bayer AG, Pharmaceuticals, Berlin, Germany.; Kristian A; Bayer AS, Thorium Conjugate Research, Oslo, Norway.; Zopf D; Bayer AG, Pharmaceuticals, Berlin, Germany.; Kamfenkel C; Bayer AG, Pharmaceuticals, Berlin, Germany.; Politz O; Bayer AG, Pharmaceuticals, Berlin, Germany.; Ellingsen C; Bayer AS, Thorium Conjugate Research, Oslo, Norway.; Hilbig J; Bayer AG, Pharmaceuticals, Berlin, Germany.; Juul MU; Minerva Imaging ApS, Oelstykke, Denmark.; Fonslet J; Minerva Imaging ApS, Oelstykke, Denmark.; Nielsen CH; Minerva Imaging ApS, Oelstykke, Denmark.; Schatz CA; Bayer AG, Pharmaceuticals, Berlin, Germany.; Bjerke RM; Bayer AS, Thorium Conjugate Research, Oslo, Norway.; Cuthbertson AS; Bayer AS, Thorium Conjugate Research, Oslo, Norway.; Mumberg D; Bayer AG, Pharmaceuticals, Berlin, Germany.; Hagemann UB; Bayer AG, Pharmaceuticals, Berlin, Germany.
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Politz, O.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어